Skip to main content

Table 3 Overall survival by groups A, B, C and D

From: Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study

Adjuvant Chemotherapy cycles Not received (A) 7–8 or 10–12 cycles (B) 4–6 or 6–9 cycles (C) ≤3 or 5 cycles (D)
P P P P
Not received (A)   < 0.001 0.004 0.924
7–8 or 10–12 cycles (B) < 0.001   0.677 < 0.001
4–6 or 6–9 cycles (C) 0.004 0.677   0.005
≤3 or 5 cycles (D) 0.924 < 0.001 0.005  
  1. Note: According to the Bonferroni method, α was adjusted by dividing 0.05 by 6, P < 0.008, statistically significant